{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T06:44:48Z","timestamp":1793256288350,"version":"4.5.0"},"reference-count":90,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,8,25]],"date-time":"2020-08-25T00:00:00Z","timestamp":1598313600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,8,25]],"date-time":"2020-08-25T00:00:00Z","timestamp":1598313600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2021,4]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Since coronavirus disease-2019\u00a0(COVID-19) outbreak in January 2020, several pieces of evidence suggested an association between the spectrum of\u00a0Guillain\u2013Barr\u00e9 syndrome (GBS) and severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). Most findings were reported in the form of case reports or case series, whereas a comprehensive overview is still lacking. We conducted a systematic review and searched for all published cases until July 20th 2020. We included 73 patients reported in 52 publications. A broad age range was affected (mean 55, min 11\u2013max 94\u00a0years) with male predominance (68.5%). Most patients showed respiratory and\/or systemic symptoms, and developed GBS manifestations after COVID-19. However, asymptomatic cases for COVID-19 were also described. The distributions of clinical variants and electrophysiological subtypes resemble those of classic GBS, with a higher prevalence of the classic sensorimotor form and the acute inflammatory demyelinating polyneuropathy, although rare variants like Miller Fisher syndrome were also reported. Cerebrospinal fluid (CSF) albuminocytological dissociation was present in around 71% cases, and CSF SARS-CoV-2 RNA was absent in all tested cases. More than 70% of patients showed a good prognosis, mostly after treatment with intravenous immunoglobulin. Patients with less favorable outcome were associated with a significantly older age in accordance with previous findings regarding both classic GBS and COVID-19. COVID-19-associated GBS seems to share most features of classic post-infectious GBS and possibly the same immune-mediated pathogenetic mechanisms. Nevertheless, more extensive epidemiological studies are needed to clarify these issues.<\/jats:p>","DOI":"10.1007\/s00415-020-10124-x","type":"journal-article","created":{"date-parts":[[2020,8,25]],"date-time":"2020-08-25T11:04:17Z","timestamp":1598353457000},"page":"1133-1170","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":291,"title":["Guillain\u2013Barr\u00e9 syndrome spectrum associated with COVID-19: an up-to-date systematic review of 73 cases"],"prefix":"10.1007","volume":"268","author":[{"given":"Samir","family":"Abu-Rumeileh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Abdelhak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Foschi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayrettin","family":"Tumani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0631-8506","authenticated-orcid":false,"given":"Markus","family":"Otto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,8,25]]},"reference":[{"key":"10124_CR1","unstructured":"WHO (2020) Coronavirus disease 2019 (COVID-19). https:\/\/www.who.int\/emergencies\/diseases\/novel-coronavirus-2019. Accessed 20 July 2002"},{"key":"10124_CR2","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2020.1127","author":"L Mao","year":"2020","unstructured":"Mao L, Jin H, Wang M et al (2020) Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol. https:\/\/doi.org\/10.1001\/jamaneurol.2020.1127","journal-title":"JAMA Neurol"},{"key":"10124_CR3","doi-asserted-by":"publisher","first-page":"105921","DOI":"10.1016\/j.clineuro.2020.105921","volume":"194","author":"V Montalvan","year":"2020","unstructured":"Montalvan V, Lee J, Bueso T et al (2020) Neurological manifestations of COVID-19 and other coronavirus infections: a systematic review. Clin Neurol Neurosurg 194:105921. https:\/\/doi.org\/10.1016\/j.clineuro.2020.105921","journal-title":"Clin Neurol Neurosurg"},{"key":"10124_CR4","doi-asserted-by":"publisher","DOI":"10.1002\/ana.25807","author":"IJ Koralnik","year":"2020","unstructured":"Koralnik IJ, Tyler KL (2020) COVID-19: a global threat to the nervous system. Ann Neurol. https:\/\/doi.org\/10.1002\/ana.25807","journal-title":"Ann Neurol"},{"key":"10124_CR5","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-020-04553-9","author":"E Agosti","year":"2020","unstructured":"Agosti E, Giorgianni A, D\u2019Amore F et al (2020) Is Guillain-Barr\u00e8 syndrome triggered by SARS-CoV-2? Case report and literature review. Neurol Sci. https:\/\/doi.org\/10.1007\/s10072-020-04553-9","journal-title":"Neurol Sci"},{"issue":"4","key":"10124_CR6","doi-asserted-by":"publisher","first-page":"e741","DOI":"10.1212\/NXI.0000000000000741","volume":"7","author":"P Alberti","year":"2020","unstructured":"Alberti P, Beretta S, Piatti M et al (2020) Guillain-Barr\u00e9 syndrome related to COVID-19 infection. Neurol Neuroimmunol Neuroinflamm 7(4):e741. https:\/\/doi.org\/10.1212\/NXI.0000000000000741","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"7","key":"10124_CR7","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1016\/j.clinph.2020.05.003","volume":"131","author":"S Arnaud","year":"2020","unstructured":"Arnaud S, Budowski C, Ng Wing Tin S et al (2020) Post SARS-CoV-2 Guillain-Barr\u00e9 syndrome. Clin Neurophysiol 131(7):1652\u20131654. https:\/\/doi.org\/10.1016\/j.clinph.2020.05.003","journal-title":"Clin Neurophysiol"},{"key":"10124_CR8","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-020-04484-5","author":"A Assini","year":"2020","unstructured":"Assini A, Benedetti L, Di Maio S et al (2020) New clinical manifestation of COVID-19 related Guillain-Barr\u00e9 syndrome highly responsive to intravenous immunoglobulins: two Italian cases. Neurol Sci. https:\/\/doi.org\/10.1007\/s10072-020-04484-5","journal-title":"Neurol Sci"},{"issue":"5","key":"10124_CR9","doi-asserted-by":"publisher","first-page":"e785","DOI":"10.1212\/nxi.0000000000000785","volume":"7","author":"K Bigaut","year":"2020","unstructured":"Bigaut K, Mallaret M, Baloglu S et al (2020) Guillain-Barr\u00e9 syndrome related to SARS-CoV-2 infection. Neurol Neuroimmunol Neuroinflamm 7(5):e785. https:\/\/doi.org\/10.1212\/nxi.0000000000000785","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10124_CR10","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-020-10014-2","author":"M Bracaglia","year":"2020","unstructured":"Bracaglia M, Naldi I, Govoni A et al (2020) Acute inflammatory demyelinating polyneuritis in association with an asymptomatic infection by SARS-CoV-2. J Neurol. https:\/\/doi.org\/10.1007\/s00415-020-10014-2","journal-title":"J Neurol"},{"issue":"6","key":"10124_CR11","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.neurol.2020.04.003","volume":"176","author":"JP Camdessanche","year":"2020","unstructured":"Camdessanche JP, Morel J, Pozzetto B et al (2020) COVID-19 may induce Guillain-Barr\u00e9 syndrome. Rev Neurol 176(6):516\u2013518. https:\/\/doi.org\/10.1016\/j.neurol.2020.04.003","journal-title":"Rev Neurol"},{"key":"10124_CR12","doi-asserted-by":"publisher","DOI":"10.1017\/cjn.2020.106","author":"JL Chan","year":"2020","unstructured":"Chan JL, Ebadi H, Sarna JR (2020) Guillain-Barr\u00e9 syndrome with facial diplegia related to SARS-CoV-2 infection. Can J Neurol Sci. https:\/\/doi.org\/10.1017\/cjn.2020.106","journal-title":"Can J Neurol Sci"},{"key":"10124_CR13","doi-asserted-by":"publisher","DOI":"10.1212\/CPJ.0000000000000880","author":"M Chan","year":"2020","unstructured":"Chan M, Han SC, Kelly S et al (2020) A case series of Guillain-Barr\u00e9 Syndrome following Covid-19 infection in New York. Neurol Clin Pract. https:\/\/doi.org\/10.1212\/CPJ.0000000000000880","journal-title":"Neurol Clin Pract"},{"key":"10124_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbi.2020.04.074","author":"M Coen","year":"2020","unstructured":"Coen M, Jeanson G, Culebras Almeida LA et al (2020) Guillain-Barr\u00e9 syndrome as a complication of SARS-CoV-2 infection. Brain Behav Immun. https:\/\/doi.org\/10.1016\/j.bbi.2020.04.074","journal-title":"Brain Behav Immun"},{"key":"10124_CR15","doi-asserted-by":"publisher","DOI":"10.1212\/CPJ.0000000000000879","author":"SA Ebrahimzadeh","year":"2020","unstructured":"Ebrahimzadeh SA, Ghoreishi A, Rahimian N (2020) Guillain-Barr\u00e9 Syndrome associated with the coronavirus disease 2019 (COVID-19). Neurol Clin Pract. https:\/\/doi.org\/10.1212\/CPJ.0000000000000879","journal-title":"Neurol Clin Pract"},{"issue":"6","key":"10124_CR16","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.neurol.2020.04.007","volume":"176","author":"H El Otmani","year":"2020","unstructured":"El Otmani H, El Moutawakil B, Rafai MA et al (2020) Covid-19 and Guillain-Barr\u00e9 syndrome: more than a coincidence! Rev Neurol 176(6):518\u2013519. https:\/\/doi.org\/10.1016\/j.neurol.2020.04.007","journal-title":"Rev Neurol"},{"key":"10124_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.medin.2020.04.015","author":"A Esteban Molina","year":"2020","unstructured":"Esteban Molina A, Mata Mart\u00ednez M, S\u00e1nchez Chueca P et al (2020) Guillain-Barr\u00e9 Syndrome associated with SARS-CoV-2 infection. Med Intensiva. https:\/\/doi.org\/10.1016\/j.medin.2020.04.015","journal-title":"Med Intensiva"},{"key":"10124_CR18","doi-asserted-by":"publisher","first-page":"577294","DOI":"10.1016\/j.jneuroim.2020.577294","volume":"346","author":"MA Farzi","year":"2020","unstructured":"Farzi MA, Ayromlou H, Jahanbakhsh N et al (2020) Guillain-Barr\u00e9 syndrome in a patient infected with SARS-CoV-2, a case report. J Neuroimmunol 346:577294. https:\/\/doi.org\/10.1016\/j.jneuroim.2020.577294","journal-title":"J Neuroimmunol"},{"key":"10124_CR19","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-020-09912-2","author":"J Fern\u00e1ndez-Dom\u00ednguez","year":"2020","unstructured":"Fern\u00e1ndez-Dom\u00ednguez J, Ameijide-Sanluis E, Garc\u00eda-Cabo C et al (2020) Miller-Fisher-like syndrome related to SARS-CoV-2 infection (COVID 19). J Neurol. https:\/\/doi.org\/10.1007\/s00415-020-09912-2","journal-title":"J Neurol"},{"key":"10124_CR20","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.26121","author":"J Finsterer","year":"2020","unstructured":"Finsterer J, Scorza FA, Ghosh R (2020) COVID-19 polyradiculitis in 24 patients without SARS-CoV-2 in the cerebro-spinal fluid. J Med Virol. https:\/\/doi.org\/10.1002\/jmv.26121","journal-title":"J Med Virol"},{"key":"10124_CR21","doi-asserted-by":"publisher","DOI":"10.1093\/tropej\/fmaa044","author":"CHM Frank","year":"2020","unstructured":"Frank CHM, Almeida TVR, Marques EA et al (2020) Guillain-Barr\u00e9 Syndrome associated with SARS-CoV-2 infection in a pediatric patient. J Trop Pediatr. https:\/\/doi.org\/10.1093\/tropej\/fmaa044","journal-title":"J Trop Pediatr"},{"key":"10124_CR22","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-020-09911-3","author":"GL Gigli","year":"2020","unstructured":"Gigli GL, Bax F, Marini A et al (2020) Guillain-Barr\u00e9 syndrome in the COVID-19 era: just an occasional cluster? J Neurol. https:\/\/doi.org\/10.1007\/s00415-020-09911-3","journal-title":"J Neurol"},{"key":"10124_CR23","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000009619","author":"C Guti\u00e9rrez-Ortiz","year":"2020","unstructured":"Guti\u00e9rrez-Ortiz C, M\u00e9ndez A, Rodrigo-Rey S et al (2020) Miller Fisher Syndrome and polyneuritis cranialis in COVID-19. Neurology. https:\/\/doi.org\/10.1212\/WNL.0000000000009619","journal-title":"Neurology"},{"key":"10124_CR24","doi-asserted-by":"publisher","DOI":"10.1111\/ene.14388","author":"R Helbok","year":"2020","unstructured":"Helbok R, Beer R, L\u00f6scher W et al (2020) Guillain-Barr\u00e9 syndrome in a patient with antibodies against SARS-COV-2. Eur J Neurol. https:\/\/doi.org\/10.1111\/ene.14388","journal-title":"Eur J Neurol"},{"key":"10124_CR25","doi-asserted-by":"publisher","DOI":"10.3174\/ajnr.A6654","author":"KL Hutchins","year":"2020","unstructured":"Hutchins KL, Jansen JH, Comer AD et al (2020) COVID-19-associated bifacial weakness with paresthesia subtype of Guillain-Barr\u00e9 syndrome. AJNR Am J Neuroradiol. https:\/\/doi.org\/10.3174\/ajnr.A6654","journal-title":"AJNR Am J Neuroradiol"},{"key":"10124_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jocn.2020.05.016","author":"DS Juliao Caama\u00f1o","year":"2020","unstructured":"Juliao Caama\u00f1o DS, Alonso Beato R (2020) Facial diplegia, a possible atypical variant of Guillain-Barr\u00e9 Syndrome as a rare neurological complication of SARS-CoV-2. J Clin Neurosci. https:\/\/doi.org\/10.1016\/j.jocn.2020.05.016","journal-title":"J Clin Neurosci"},{"key":"10124_CR27","doi-asserted-by":"publisher","DOI":"10.1093\/jpids\/piaa086","author":"M Khalifa","year":"2020","unstructured":"Khalifa M, Zakaria F, Ragab Y et al (2020) Guillain-Barre syndrome associated with SARS-CoV-2 Detection and a COVID-19 infection in a child. J Pediatric Infect Dis Soc. https:\/\/doi.org\/10.1093\/jpids\/piaa086","journal-title":"J Pediatric Infect Dis Soc"},{"key":"10124_CR28","doi-asserted-by":"publisher","DOI":"10.1111\/ene.14398","author":"D Kilinc","year":"2020","unstructured":"Kilinc D, van de Pasch S, Doets AY et al (2020) Guillain-Barr\u00e9 syndrome after SARS-CoV-2 infection. Eur J Neurol. https:\/\/doi.org\/10.1111\/ene.14398","journal-title":"Eur J Neurol"},{"key":"10124_CR29","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s42466-020-00066-0","volume":"2","author":"A Lampe","year":"2020","unstructured":"Lampe A, Winschel A, Lang C et al (2020) Guillain-Barr\u00e9 syndrome and SARS-CoV-2. Neurol Res Pract 2:19. https:\/\/doi.org\/10.1186\/s42466-020-00066-0","journal-title":"Neurol Res Pract"},{"key":"10124_CR30","doi-asserted-by":"publisher","DOI":"10.3174\/ajnr.A6609","author":"JE Lantos","year":"2020","unstructured":"Lantos JE, Strauss SB, Lin E (2020) COVID-19-associated Miller Fisher Syndrome: MRI findings. AJNR Am J Neuroradiol. https:\/\/doi.org\/10.3174\/ajnr.A6609","journal-title":"AJNR Am J Neuroradiol"},{"key":"10124_CR31","doi-asserted-by":"publisher","DOI":"10.1111\/ene.14368","author":"AM Lascano","year":"2020","unstructured":"Lascano AM, Epiney JB, Coen M et al (2020) SARS-CoV-2 and Guillain-Barr\u00e9 syndrome: AIDP variant with favorable outcome. Eur J Neurol. https:\/\/doi.org\/10.1111\/ene.14368","journal-title":"Eur J Neurol"},{"key":"10124_CR32","doi-asserted-by":"publisher","DOI":"10.1007\/s13365-020-00858-9","author":"P Manganotti","year":"2020","unstructured":"Manganotti P, Pesavento V et al (2020) Miller Fisher syndrome diagnosis and treatment in a patient with SARS-CoV-2. J Neurovirol. https:\/\/doi.org\/10.1007\/s13365-020-00858-9","journal-title":"J Neurovirol"},{"key":"10124_CR33","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.26289","author":"P Manganotti","year":"2020","unstructured":"Manganotti P, Bellavita G, D\u2019Acunto L et al (2020) Clinical neurophysiology and cerebrospinal liquor analysis to detect Guillain Barr\u00e9 syndrome and polyneuritis cranialis in COVID-19 patients: a case series. J Med Virol. https:\/\/doi.org\/10.1002\/jmv.26289","journal-title":"J Med Virol"},{"issue":"4","key":"10124_CR34","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.nrl.2020.04.004","volume":"35","author":"J Marta-Enguita","year":"2020","unstructured":"Marta-Enguita J, Rubio-Baines I, Gast\u00f3n-Zubimendi I (2020) Fatal Guillain-Barre syndrome after infection with SARS-CoV-2. S\u00edndrome de Guillain-Barr\u00e9 fatal tras infecci\u00f3n por el virus SARS-CoV-2. Neurologia 35(4):265\u2013267. https:\/\/doi.org\/10.1016\/j.nrl.2020.04.004","journal-title":"Neurologia"},{"issue":"3","key":"10124_CR35","doi-asserted-by":"publisher","first-page":"156","DOI":"10.34172\/icnj.2020.18","volume":"7","author":"H Mozhdehipanah","year":"2020","unstructured":"Mozhdehipanah H, Paybast S, Gorji R (2020) Guillain-Barr\u00e9 syndrome as a neurological complication of COVID-19 infection: a case series and review of the literature. Int Clin Neurosci J 7(3):156\u2013161","journal-title":"Int Clin Neurosci J"},{"key":"10124_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2020.05.029","author":"E Naddaf","year":"2020","unstructured":"Naddaf E, Laughlin RS, Klein CJ et al (2020) Guillain-Barre syndrome in a patient with evidence of recent SARS-CoV-2 infection. Mayo Clin Proc. https:\/\/doi.org\/10.1016\/j.mayocp.2020.05.029","journal-title":"Mayo Clin Proc"},{"key":"10124_CR37","doi-asserted-by":"publisher","DOI":"10.1002\/mus.26992","author":"E Oguz-Akarsu","year":"2020","unstructured":"Oguz-Akarsu E, Ozpar R, Mirzayev H et al (2020) Guillain-Barr\u00e9 syndrome in a patient with minimal symptoms of COVID-19 infection. Muscle Nerve. https:\/\/doi.org\/10.1002\/mus.26992","journal-title":"Muscle Nerve"},{"issue":"6","key":"10124_CR38","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1007\/s10072-020-04449-8","volume":"41","author":"D Ottaviani","year":"2020","unstructured":"Ottaviani D, Boso F, Tranquillini E et al (2020) Early Guillain-Barr\u00e9 syndrome in coronavirus disease 2019 (COVID-19): a case report from an Italian COVID-hospital. Neurol Sci 41(6):1351\u20131354. https:\/\/doi.org\/10.1007\/s10072-020-04449-8","journal-title":"Neurol Sci"},{"key":"10124_CR39","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-020-09849-6","author":"M Padroni","year":"2020","unstructured":"Padroni M, Mastrangelo V, Asioli GM et al (2020) Guillain-Barr\u00e9 syndrome following COVID-19: new infection, old complication? J Neurol. https:\/\/doi.org\/10.1007\/s00415-020-09849-6","journal-title":"J Neurol"},{"key":"10124_CR40","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awaa240","author":"RW Paterson","year":"2020","unstructured":"Paterson RW, Brown RL, Benjamin L et al (2020) The emerging spectrum of COVID-19 neurology: clinical, radiological and laboratory findings. Brain. https:\/\/doi.org\/10.1093\/brain\/awaa240","journal-title":"Brain"},{"issue":"4","key":"10124_CR41","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1097\/NRL.0000000000000291","volume":"25","author":"S Paybast","year":"2020","unstructured":"Paybast S, Gorji R, Mavandadi S (2020) Guillain-Barr\u00e9 syndrome as a neurological complication of novel COVID-19 infection: a case report and review of the literature. Neurologist 25(4):101\u2013103. https:\/\/doi.org\/10.1097\/NRL.0000000000000291","journal-title":"Neurologist"},{"key":"10124_CR42","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-020-09897-y","author":"T Pfefferkorn","year":"2020","unstructured":"Pfefferkorn T, Dabitz R, von Wernitz-Keibel T et al (2020) Acute polyradiculoneuritis with locked-in syndrome in a patient with Covid-19. J Neurol. https:\/\/doi.org\/10.1007\/s00415-020-09897-y","journal-title":"J Neurol"},{"issue":"4","key":"10124_CR43","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1097\/CND.0000000000000309","volume":"21","author":"S Rana","year":"2020","unstructured":"Rana S, Lima AA, Chandra R et al (2020) Novel coronavirus (COVID-19)-associated Guillain-Barr\u00e9 syndrome: case report. J Clin Neuromuscul Dis 21(4):240\u2013242. https:\/\/doi.org\/10.1097\/CND.0000000000000309","journal-title":"J Clin Neuromuscul Dis"},{"key":"10124_CR44","doi-asserted-by":"publisher","DOI":"10.1111\/ene.14383","author":"JA Reyes-Bueno","year":"2020","unstructured":"Reyes-Bueno JA, Garc\u00eda-Trujillo L, Urbaneja P et al (2020) Miller-Fisher syndrome after SARS-CoV-2 infection. Eur J Neurol. https:\/\/doi.org\/10.1111\/ene.14383","journal-title":"Eur J Neurol"},{"key":"10124_CR45","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-020-09907-z","author":"N Riva","year":"2020","unstructured":"Riva N, Russo T, Falzone YM et al (2020) Post-infectious Guillain-Barr\u00e9 syndrome related to SARS-CoV-2 infection: a case report. J Neurol. https:\/\/doi.org\/10.1007\/s00415-020-09907-z","journal-title":"J Neurol"},{"key":"10124_CR46","doi-asserted-by":"publisher","DOI":"10.7861\/clinmed.2020-0213","author":"A Sancho-Salda\u00f1a","year":"2020","unstructured":"Sancho-Salda\u00f1a A, Lambea-Gil \u00c1, Liesa JLC et al (2020) Guillain-Barr\u00e9 syndrome associated with leptomeningeal enhancement following SARS-CoV-2 infection. Clin Med. https:\/\/doi.org\/10.7861\/clinmed.2020-0213","journal-title":"Clin Med"},{"key":"10124_CR47","doi-asserted-by":"publisher","DOI":"10.1111\/jns.12382","author":"E Scheidl","year":"2020","unstructured":"Scheidl E, Canseco DD, Hadji-Naumov A et al (2020) Guillain-Barr\u00e9 syndrome during SARS-CoV-2 pandemic: a case report and review of recent literature. J Peripher Nerv Syst. https:\/\/doi.org\/10.1111\/jns.12382","journal-title":"J Peripher Nerv Syst"},{"key":"10124_CR48","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.jocn.2020.04.062","volume":"76","author":"Z Sedaghat","year":"2020","unstructured":"Sedaghat Z, Karimi N (2020) Guillain Barre syndrome associated with COVID-19 infection: a case report. J Clin Neurosci 76:233\u2013235. https:\/\/doi.org\/10.1016\/j.jocn.2020.04.062","journal-title":"J Clin Neurosci"},{"key":"10124_CR49","doi-asserted-by":"crossref","unstructured":"Sidig A, Abbasher K, Abbasher H et al. (2020). COVID-19 and Guillain-Barre syndrome case report. J Neurol Neurobiol 6(3)","DOI":"10.21203\/rs.3.rs-48327\/v1"},{"key":"10124_CR50","doi-asserted-by":"publisher","DOI":"10.1002\/mus.26988","author":"XW Su","year":"2020","unstructured":"Su XW, Palka SV, Rao RR et al (2020) SARS-CoV-2-associated Guillain-Barr\u00e9 syndrome with dysautonomia. Muscle Nerve. https:\/\/doi.org\/10.1002\/mus.26988","journal-title":"Muscle Nerve"},{"issue":"7","key":"10124_CR51","doi-asserted-by":"publisher","first-page":"e236536","DOI":"10.1136\/bcr-2020-236536","volume":"13","author":"MY Tiet","year":"2020","unstructured":"Tiet MY, AlShaikh N (2020) Guillain-Barr\u00e9 syndrome associated with COVID-19 infection: a case from the UK. BMJ Case Rep 13(7):e236536","journal-title":"BMJ Case Rep"},{"key":"10124_CR52","doi-asserted-by":"publisher","DOI":"10.1056\/nejmc2009191","author":"G Toscano","year":"2020","unstructured":"Toscano G, Palmerini F, Ravaglia S et al (2020) Guillain-Barr\u00e9 syndrome associated with SARS-CoV-2. N Engl J Med. https:\/\/doi.org\/10.1056\/nejmc2009191","journal-title":"N Engl J Med"},{"issue":"4","key":"10124_CR53","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.nrl.2020.04.007","volume":"35","author":"A Velayos Gal\u00e1n","year":"2020","unstructured":"Velayos Gal\u00e1n A, Del Saz Saucedo P, Peinado Postigo F et al (2020) Guillain-Barr\u00e9 syndrome associated with SARS-CoV-2 infection. S\u00edndrome de Guillain-Barr\u00e9 asociado a infecci\u00f3n por SARS-CoV-2. Neurologia 35(4):268\u2013269. https:\/\/doi.org\/10.1016\/j.nrl.2020.04.007","journal-title":"Neurologia"},{"key":"10124_CR54","doi-asserted-by":"publisher","first-page":"e00771","DOI":"10.1016\/j.idcr.2020.e00771","volume":"20","author":"A Virani","year":"2020","unstructured":"Virani A, Rabold E, Hanson T et al (2020) Guillain-Barr\u00e9 Syndrome associated with SARS-CoV-2 infection. IDCases 20:e00771. https:\/\/doi.org\/10.1016\/j.idcr.2020.e00771","journal-title":"IDCases"},{"issue":"6","key":"10124_CR55","doi-asserted-by":"publisher","first-page":"e236182","DOI":"10.1136\/bcr-2020-236182","volume":"13","author":"S Webb","year":"2020","unstructured":"Webb S, Wallace VC, Martin-Lopez D et al (2020) Guillain-Barr\u00e9 syndrome following COVID-19: a newly emerging post-infectious complication. BMJ Case Rep 13(6):e236182. https:\/\/doi.org\/10.1136\/bcr-2020-236182","journal-title":"BMJ Case Rep"},{"issue":"5","key":"10124_CR56","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/S1474-4422(20)30109-5","volume":"19","author":"H Zhao","year":"2020","unstructured":"Zhao H, Shen D, Zhou H et al (2020) Guillain-Barr\u00e9 syndrome associated with SARS-CoV-2 infection: causality or coincidence? Lancet Neurol 19(5):383\u2013384. https:\/\/doi.org\/10.1016\/S1474-4422(20)30109-5","journal-title":"Lancet Neurol"},{"issue":"11","key":"10124_CR57","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/s41582-019-0250-9","volume":"15","author":"SE Leonhard","year":"2019","unstructured":"Leonhard SE, Mandarakas MR, Gondim FAA et al (2019) Diagnosis and management of Guillain-Barr\u00e9 syndrome in ten steps. Nat Rev Neurol 15(11):671\u2013683. https:\/\/doi.org\/10.1038\/s41582-019-0250-9","journal-title":"Nat Rev Neurol"},{"issue":"10045","key":"10124_CR58","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/S0140-6736(16)00339-1","volume":"388","author":"HJ Willison","year":"2016","unstructured":"Willison HJ, Jacobs BC, van Doorn PA (2016) Guillain-Barr\u00e9 syndrome. Lancet 388(10045):717\u2013727. https:\/\/doi.org\/10.1016\/S0140-6736(16)00339-1","journal-title":"Lancet"},{"key":"10124_CR59","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/s41572-018-0027-2","volume":"4","author":"BC Kieseier","year":"2018","unstructured":"Kieseier BC, Mathey EK, Sommer C et al (2018) Immune-mediated neuropathies. Nat Rev Dis Primers 4:31","journal-title":"Nat Rev Dis Primers"},{"issue":"11","key":"10124_CR60","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1038\/nrneurol.2015.115","volume":"11","author":"BR Wakerley","year":"2015","unstructured":"Wakerley BR, Yuki N (2015) Polyneuritis cranialis-subtype of Guillain-Barr\u00e9 syndrome? Nat Rev Neurol 11(11):664. https:\/\/doi.org\/10.1038\/nrneurol.2015.115","journal-title":"Nat Rev Neurol"},{"issue":"12","key":"10124_CR61","doi-asserted-by":"publisher","first-page":"2586","DOI":"10.1016\/j.clinph.2018.09.025","volume":"129","author":"A Uncini","year":"2018","unstructured":"Uncini A, Kuwabara S (2018) The electrodiagnosis of Guillain-Barr\u00e9 syndrome subtypes: where do we stand? Clin Neurophysiol 129(12):2586\u20132593. https:\/\/doi.org\/10.1016\/j.clinph.2018.09.025","journal-title":"Clin Neurophysiol"},{"key":"10124_CR62","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000009921","author":"F Costello","year":"2020","unstructured":"Costello F, Dalakas MC (2020) Cranial Neuropathies and COVID-19: neurotropism and Autoimmunity. Neurology. https:\/\/doi.org\/10.1212\/WNL.0000000000009921","journal-title":"Neurology"},{"issue":"3","key":"10124_CR63","doi-asserted-by":"publisher","first-page":"227","DOI":"10.3988\/jcn.2017.13.3.227","volume":"13","author":"JE Kim","year":"2010","unstructured":"Kim JE, Heo JH, Kim HO et al (2010) Neurological complications during treatment of Middle East Respiratory Syndrome. J Clin Neurol 13(3):227\u2013233","journal-title":"J Clin Neurol"},{"key":"10124_CR64","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-020-09929-7","author":"Z Zhou","year":"2020","unstructured":"Zhou Z, Kang H, Li S et al (2020) Understanding the neurotropic characteristics of SARS-CoV-2: from neurological manifestations of COVID-19 to potential neurotropic mechanisms. J Neurol. https:\/\/doi.org\/10.1007\/s00415-020-09929-7","journal-title":"J Neurol"},{"key":"10124_CR65","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1111\/j.1471-1842.2009.00848.x","volume":"26","author":"MJ Grant","year":"2009","unstructured":"Grant MJ, Booth A (2009) A typology of reviews: an analysis of 14 review types and associated methodologies. Health Info Libr J 26:91\u2013108","journal-title":"Health Info Libr J"},{"issue":"Pt 1","key":"10124_CR66","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1093\/brain\/awt285","volume":"137","author":"C Fokke","year":"2014","unstructured":"Fokke C, van den Berg B, Drenthen J et al (2014) Diagnosis of Guillain-Barre syndrome and validation of Brighton criteria. Brain 137(Pt 1):33\u201343","journal-title":"Brain"},{"key":"10124_CR67","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/978-81-322-1777-0_6","volume":"807","author":"M Desforges","year":"2014","unstructured":"Desforges M, Le Coupanec A, Brison E et al (2014) Neuroinvasive and neurotropic human respiratory coronaviruses: potential neurovirulent agents in humans. Adv Exp Med Biol 807:75\u201396. https:\/\/doi.org\/10.1007\/978-81-322-1777-0_6","journal-title":"Adv Exp Med Biol"},{"issue":"5","key":"10124_CR68","doi-asserted-by":"publisher","first-page":"e781","DOI":"10.1212\/NXI.0000000000000781","volume":"7","author":"MC Dalakas","year":"2020","unstructured":"Dalakas MC (2020) Guillain-Barr\u00e9 syndrome: the first documented COVID-19-triggered autoimmune neurologic disease: More to come with myositis in the offing. Neurol Neuroimmunol Neuroinflamm 7(5):e781","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10124_CR69","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-020-09974-2","author":"L Wang","year":"2020","unstructured":"Wang L, Shen Y, Li M et al (2020) Clinical manifestations and evidence of neurological involvement in 2019 novel coronavirus SARS-CoV-2: a systematic review and meta-analysis. J Neurol. https:\/\/doi.org\/10.1007\/s00415-020-09974-2","journal-title":"J Neurol"},{"issue":"18","key":"10124_CR70","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","volume":"382","author":"WJ Guan","year":"2020","unstructured":"Guan WJ, Ni ZY, Hu Y et al (2020) Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 382(18):1708\u20131720. https:\/\/doi.org\/10.1056\/NEJMoa2002032","journal-title":"N Engl J Med"},{"key":"10124_CR71","doi-asserted-by":"publisher","first-page":"152","DOI":"10.3389\/fpubh.2020.00152","volume":"8","author":"JM Jin","year":"2020","unstructured":"Jin JM, Bai P, He W et al (2020) Gender differences in patients with COVID-19: focus on severity and mortality. Front Public Health 8:152. https:\/\/doi.org\/10.3389\/fpubh.2020.00152","journal-title":"Front Public Health"},{"issue":"9","key":"10124_CR72","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1001\/jamaneurol.2018.1058","volume":"75","author":"E Dirlikov","year":"2018","unstructured":"Dirlikov E, Major CG, Medina NA et al (2018) Clinical features of Guillain-Barr\u00e9 syndrome with vs without zika virus infection, Puerto Rico, 2016. JAMA Neurol 75(9):1089\u20131097. https:\/\/doi.org\/10.1001\/jamaneurol.2018.1058","journal-title":"JAMA Neurol"},{"key":"10124_CR73","unstructured":"ECDC (2020) https:\/\/covid19-surveillance-report.ecdc.europa.eu, Accessed 20 July 2002"},{"key":"10124_CR74","unstructured":"WHO (2020) https:\/\/www.who.int\/emergencies\/diseases\/novel-coronavirus-2019\/situation-reports\/, Accessed 20 July 2020"},{"issue":"16","key":"10124_CR75","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1056\/NEJMoa1605564","volume":"375","author":"B Parra","year":"2016","unstructured":"Parra B, Lizarazo J, Jim\u00e9nez-Arango JA et al (2016) Guillain-Barr\u00e9 Syndrome Associated with Zika Virus Infection in Colombia. N Engl J Med 375(16):1513\u20131523","journal-title":"N Engl J Med"},{"key":"10124_CR76","doi-asserted-by":"publisher","DOI":"10.1007\/s11481-020-09932-9","author":"YH Balcioglu","year":"2020","unstructured":"Balcioglu YH, Yesilkaya UH, Gokcay H et al (2020) May the central nervous system be fogged by the cytokine storm in COVID-19?: an Appraisal. J Neuroimmune Pharmacol. https:\/\/doi.org\/10.1007\/s11481-020-09932-9","journal-title":"J Neuroimmune Pharmacol"},{"key":"10124_CR77","doi-asserted-by":"publisher","DOI":"10.1016\/j.cytogfr.2020.06.001","author":"VJ Costela-Ruiz","year":"2020","unstructured":"Costela-Ruiz VJ, Illescas-Montes R, Puerta-Puerta JM et al (2020) SARS-CoV-2 infection: the role of cytokines in COVID-19 disease. Cytokine Growth Factor Rev. https:\/\/doi.org\/10.1016\/j.cytogfr.2020.06.001","journal-title":"Cytokine Growth Factor Rev"},{"issue":"29","key":"10124_CR78","doi-asserted-by":"publisher","first-page":"4556","DOI":"10.2174\/138161212802502143","volume":"18","author":"H Tumani","year":"2012","unstructured":"Tumani H, Brettschneider J (2012) Biochemical markers of autoimmune diseases of the nervous system. Curr Pharm Des 18(29):4556\u20134563. https:\/\/doi.org\/10.2174\/138161212802502143","journal-title":"Curr Pharm Des"},{"issue":"3","key":"10124_CR79","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1159\/000052111","volume":"45","author":"FG Van der Mech\u00e9","year":"2001","unstructured":"Van der Mech\u00e9 FG, Van Doorn PA, Meulstee J et al (2001) GBS-consensus group of the Dutch Neuromuscular Research Support Centre. Diagnostic and classification criteria for the Guillain-Barr\u00e9 syndrome. Eur Neurol 45(3):133\u2013139. https:\/\/doi.org\/10.1159\/000052111","journal-title":"Eur Neurol"},{"issue":"1","key":"10124_CR80","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s00415-009-0097-x","volume":"256","author":"J Brettschneider","year":"2009","unstructured":"Brettschneider J, Petzold A, S\u00fcssmuth S et al (2009) CSF biomarkers in GBS\u2014where do we stand? J Neurol 256(1):3\u201312","journal-title":"J Neurol"},{"key":"10124_CR81","doi-asserted-by":"publisher","DOI":"10.1111\/ene.14473","author":"M Senel","year":"2020","unstructured":"Senel M, Abu-Rumeileh S, Michel D et al (2020) Miller-Fisher syndrome after COVID-19: neurochemical markers as an early sign of nervous system involvement. Eur J Neurol. https:\/\/doi.org\/10.1111\/ene.14473","journal-title":"Eur J Neurol"},{"key":"10124_CR82","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-020-10050-y","author":"M Ameres","year":"2020","unstructured":"Ameres M, Brandstetter S, Toncheva AA et al (2020) Association of neuronal injury blood marker neurofilament light chain with mild-to-moderate COVID-19. J Neurol. https:\/\/doi.org\/10.1007\/s00415-020-10050-y","journal-title":"J Neurol"},{"issue":"2","key":"10124_CR83","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s00415-016-8204-2","volume":"264","author":"J Berciano","year":"2017","unstructured":"Berciano J, Sedano MJ, Pelayo-Negro AL et al (2017) Proximal nerve lesions in early Guillain-Barr\u00e9 syndrome: implications for pathogenesis and disease classification. J Neurol 264(2):221\u2013236. https:\/\/doi.org\/10.1007\/s00415-016-8204-2","journal-title":"J Neurol"},{"issue":"14","key":"10124_CR84","doi-asserted-by":"publisher","first-page":"e3257","DOI":"10.1097\/MD.0000000000003257","volume":"95","author":"L Watrin","year":"2016","unstructured":"Watrin L, Ghawch\u00e9 F, Larre P et al (2016) Guillain-Barr\u00e9 Syndrome (42 cases) occurring during a zika virus outbreak in French Polynesia. Medicine 95(14):e3257. https:\/\/doi.org\/10.1097\/MD.0000000000003257","journal-title":"Medicine"},{"issue":"3","key":"10124_CR85","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1055\/s-0032-1329196","volume":"32","author":"X Arcila-Londono","year":"2020","unstructured":"Arcila-Londono X, Lewis RA (2020) Guillain-Barr\u00e9 syndrome. Semin Neurol 32(3):179\u2013186. https:\/\/doi.org\/10.1055\/s-0032-1329196","journal-title":"Semin Neurol"},{"issue":"6","key":"10124_CR86","doi-asserted-by":"publisher","first-page":"e501","DOI":"10.1212\/NXI.0000000000000501","volume":"5","author":"K Yoshikawa","year":"2018","unstructured":"Yoshikawa K, Kuwahara M, Morikawa M et al (2018) Varied antibody reactivities and clinical relevance in anti-GQ1b antibody-related diseases. Neurol Neuroimmunol Neuroinflamm 5(6):e501","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"6","key":"10124_CR87","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1002\/ana.21976","volume":"67","author":"C Walgaard","year":"2010","unstructured":"Walgaard C, Lingsma HF, Ruts L et al (2010) Prediction of respiratory insufficiency in Guillain-Barr\u00e9 syndrome. Ann Neurol 67(6):781\u2013787. https:\/\/doi.org\/10.1002\/ana.21976","journal-title":"Ann Neurol"},{"issue":"7","key":"10124_CR88","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/S1474-4422(07)70130-8","volume":"6","author":"R van Koningsveld","year":"2007","unstructured":"van Koningsveld R, Steyerberg EW, Hughes RA et al (2007) A clinical prognostic scoring system for Guillain-Barr\u00e9 syndrome. Lancet Neurol 6(7):589\u2013594. https:\/\/doi.org\/10.1016\/S1474-4422(07)70130-8","journal-title":"Lancet Neurol"},{"issue":"5","key":"10124_CR89","doi-asserted-by":"publisher","first-page":"2001112","DOI":"10.1038\/nrneurol.2009.75","volume":"55","author":"Y Liu","year":"2020","unstructured":"Liu Y, Mao B, Liang S et al (2020) Association between age and clinical characteristics and outcomes of COVID-19. Eur Respir J 55(5):2001112. https:\/\/doi.org\/10.1183\/13993003.01112-2020","journal-title":"Eur Respir J"},{"issue":"7","key":"10124_CR90","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1038\/nrneurol.2009.75","volume":"5","author":"W Zink","year":"2009","unstructured":"Zink W, Kollmar R, Schwab S (2009) Critical illness polyneuropathy and myopathy in the intensive care unit. Nat Rev Neurol 5(7):372\u2013379. https:\/\/doi.org\/10.1038\/nrneurol.2009.75","journal-title":"Nat Rev Neurol"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-020-10124-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-020-10124-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-020-10124-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,24]],"date-time":"2021-08-24T23:42:51Z","timestamp":1629848571000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-020-10124-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,25]]},"references-count":90,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["10124"],"URL":"https:\/\/doi.org\/10.1007\/s00415-020-10124-x","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,25]]},"assertion":[{"value":"14 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest related to the content of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"For the present study, no authorization to an Ethics Committee was asked, because the original reports, nor this work, provided any personal information of the patients.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical standard"}}]}}